Drugs / H2N3 MO 2003/AA ca
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01175122 | Sep 2010 → Apr 2011 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H2N3 MO 2003/AA ca | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01175122 ↗ |
| Modality | Vaccine | “This is a live attenuated vaccine” NCT01175122 ↗ |
| Route | Intranasal | “They will receive one nasal spray administration of the vaccine” NCT01175122 ↗ |